The situation regarding avian influenza continues to evolve in Europe and globally, with reports of new outbreaks in birds and occasional infections in mammals. Sporadic human infections have been reported in countries outside the EU, while the risk to the public in the EU remains low.
Influenza activity had been decreasing across the Region until week 4/2023, following a peak at week 51/2022, but has fluctuated around 25% since week 6/2023 due to increased type B virus circulation.
As of 3 March 2023, ECDC will de-escalate BA.2, BA.4 and BA.5 from its list of SARS-CoV-2 variants of concern (VOC), as these parental lineages are no longer circulating.
In February 2023, Cambodia reported a family cluster in Sithor Kandal district, Prey Veng province, with two people (a girl and her father) infected with avian influenza A(H5N1) virus.
Seasonal influenza activity had been decreasing across the Region after a peak at week 51/2022 until week 4/2023 and increased again up to week 7/2023 due to increased type B virus circulation.
Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.
Seasonal influenza activity is still widespread in the EU/EEA, with an increase in positivity noted between week 5 and 7/2023 related to increased type B virus circulation.
Seasonal influenza activity is still widespread in the EU/EEA, with an increase in positivity in sentinel primary care starting from week 5/2023 related to increased type B virus circulation.